Xconomy National

Archives

by in

Entry	Author	Date	Location
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Arena Passes Small Study, in Bid to Answer FDA Questions About Obesity Drug	Luke Timmerman	08/02/11	San Diego
A San Diego Sampler from the War on Diabetes	Bruce V. Bigelow	06/24/11	San Diego
FDA Rejects Orexigen’s Weight-Loss Drug, Arena Lays Off 66, ResMed CEO Jumps to CareFusion, & More San Diego Life Sciences News	Bruce V. Bigelow	02/03/11	San Diego
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug	Luke Timmerman	01/27/11	San Diego
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients	Luke Timmerman	11/09/10	San Diego
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing	Luke Timmerman	10/25/10	San Diego
FDA Panel Votes Against Arena’s Weight-Loss Drug, ImThera Encouraged by Early Test Results, Novartis Wins FDA Approval for MS Pill, & More San Diego Life Sciences News	Bruce V. Bigelow	09/23/10	San Diego
Lorcaserin Weight-Loss Trials Weigh Heavily on Arena, Ramius Raises Offer to Buy Cypress Bio, Santarus Adds to Its Drug Portfolio, & More San Diego Life Sciences News	Bruce V. Bigelow	09/16/10	San Diego
Arena Obesity Drug Was Effective by ‘Slim Margin,’ FDA Staff Raises Rat Cancer Concern; Shares Tumble	Luke Timmerman	09/14/10	San Diego
Lessons Learned About the Outlook for New Obesity Drug Approval	Tom Hughes	07/16/10	National
Arena Signs Deal With Eisai for Lorcaserin, Qualcomm CEO Identifies Two Opportunities in Mobile Health, & More San Diego Life Sciences News	Bruce V. Bigelow	07/08/10	San Diego
Arena Strikes Deal with Eisai to Market Obesity Drug in U.S., Pocketing $50M Upfront	Luke Timmerman	07/01/10	San Diego
Arena Adds $35M From Deerfield	Luke Timmerman	06/03/10	San Diego
Arena FDA Panel Set for Sept. 16	Luke Timmerman	06/02/10	San Diego
Arena Gets October FDA Deadline	Luke Timmerman	02/26/10	San Diego
Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial	Luke Timmerman	12/23/09	San Diego
Arena Positions Weight Loss Drug as the One That Won’t Raise Your Blood Pressure	Luke Timmerman	10/27/09	San Diego
Arena Obesity Drug Passes Second Trial, Aims to Sell Safe Option for Millions of People	Luke Timmerman	09/18/09	San Diego
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News	Bruce V. Bigelow	09/10/09	San Diego
Arena Eagerly Awaits Answer to $1 Billion Question: Does It Have a Big-Time Obesity Drug?	Luke Timmerman	09/08/09	San Diego
Arena Raises $52.1M in Offering	Bruce V. Bigelow	07/09/09	San Diego
Arena Lines Up $100 Million in Final Push for Obesity Drug	Bruce V. Bigelow	06/17/09	San Diego
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News	Bruce V. Bigelow	06/11/09	San Diego
Arena Obesity Drug Helps Patients Shed a Few Pounds, Lower Risk of Heart Disease	Luke Timmerman	06/06/09	San Diego
Wireless Medicine Gets $45M Booster Shot, Arena’s Weight-Loss Trial Underwhelms Wall Street, Venter’s Synthetic Genomics About to Ramp Up, & Other San Diego BizTech News	Bruce V. Bigelow	04/06/09	San Diego
Arena Obesity Drug Helps Patients Lose Weight, Without Heart Damage	Luke Timmerman	03/30/09	San Diego
Arena Gets $50M Commitment	Luke Timmerman	03/24/09	San Diego
Arena Weight Loss Drug Approaches Critical Turning Point Next Month	Luke Timmerman	02/11/09	San Diego
Arena Insomnia Pill Fails in Clinical Trial, Halts Development of Drug	Luke Timmerman	12/09/08	San Diego
Page 1 of 2	next page »